Resilient Clinical Trial Infrastructure in Response to the COVID-19 Pandemic: Lessons Learned from the TOGETHER Randomized Platform Clinical Trial

In response to the COVID-19 pandemic, clinical research groups across the world developed trial protocols to evaluate the safety and efficacy of treatments for COVID-19. Despite this initial enthusiasm, only a small portion of these protocols were implemented. Of those implemented, a fraction succes...

Descripción completa

Detalles Bibliográficos
Autores principales: Forrest, Jamie I., Rawat, Angeli, Duailibe, Felipe, Guo, Christina M., Sprague, Sheila, McKay, Paula, Reis, Gilmar, Mills, Edward J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832890/
https://www.ncbi.nlm.nih.gov/pubmed/34996047
http://dx.doi.org/10.4269/ajtmh.21-1202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832890/
https://www.ncbi.nlm.nih.gov/pubmed/34996047
http://dx.doi.org/10.4269/ajtmh.21-1202

Ejemplares similares